InsidersTradesSigma
Track the Insight Molecular Diagnostics Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 15 June 2026 (Attribution). Among the most active insiders: Arno Andrew. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Insight Molecular Diagnostics Inc. is a company focused on developing molecular diagnostic tests. It aims to enhance healthcare through innovative solutions.